CAMP — CAMP4 Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $39.31m
- -$24.56m
- $0.65m
Annual cashflow statement for CAMP4 Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -44.2 | -49.3 | -51.8 |
| Depreciation | |||
| Non-Cash Items | 3.07 | 4.73 | 5.86 |
| Other Non-Cash Items | |||
| Changes in Working Capital | 1.7 | -1.27 | -1.33 |
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | -38.5 | -44.2 | -45.6 |
| Capital Expenditures | -4.03 | -0.678 | -0.441 |
| Purchase of Fixed Assets | |||
| Cash from Investing Activities | -4.03 | -0.678 | -0.441 |
| Financing Cash Flow Items | 0 | 0.438 | -4.44 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 100 | 0.301 | 71.7 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 57.6 | -44.5 | 25.7 |